Medicine Man Technologies Inc
General ticker "SHWZ" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $6.2M
Medicine Man Technologies Inc does not follow the US Stock Market performance with the rate: -44.3%.
Estimated limits based on current volatility of 99.9%: low 0.00$, high 0.05$
Factors to consider:
- Company does not operate outside US (retrieved using AI)
- Current price 94.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.37$, 0.80$]
- 2024-12-30 to 2025-12-30 estimated range: [0.39$, 0.81$]
Financial Metrics affecting the SHWZ estimates:
- Negative: Non-GAAP EPS, $ of -0.58 <= 0.10
- Positive: Operating cash flow per share per price, % of 33.26 > 12.76
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.50 <= 0.74
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: 1.03 < Operating profit margin, % of 1.91
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term SHWZ quotes
Long-term SHWZ plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $108.42MM | $159.38MM | $172.45MM |
| Operating Expenses | $98.01MM | $146.52MM | $169.16MM |
| Operating Income | $10.41MM | $12.85MM | $3.29MM |
| Non-Operating Income | $8.51MM | $-16.42MM | $-18.10MM |
| Interest Expense | $7.01MM | $30.14MM | $32.07MM |
| Income(Loss) | $18.92MM | $-3.57MM | $-14.81MM |
| Taxes | $4.40MM | $14.90MM | $19.74MM |
| Profit(Loss) | $14.52MM | $-18.47MM | $-34.55MM |
| Stockholders Equity | $133.57MM | $132.16MM | $119.29MM |
| Inventory | $11.12MM | $22.55MM | $25.79MM |
| Assets | $285.03MM | $322.88MM | $358.14MM |
| Operating Cash Flow | $57.33MM | $11.39MM | $12.20MM |
| Capital expenditure | $5.67MM | $14.81MM | $10.62MM |
| Investing Cash Flow | $-81.16MM | $-79.18MM | $-26.44MM |
| Financing Cash Flow | $129.00MM | $0.34MM | $-5.46MM |
| Earnings Per Share* | $0.17 | $-0.34 | $-0.26 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.